| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.091 | 0.04 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |